» Articles » PMID: 20525652

Recent Advances in the Pathophysiology of Asthma

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2010 Jun 8
PMID 20525652
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

There has been an increased understanding, over the past 2 decades, that asthma is a chronic, immunologically mediated condition with a disturbance of the normal airway repair mechanism, which results in inflammatory changes and airway remodeling. The airway inflammation and remodeling together likely explain the clinical manifestations of asthma. The mechanisms by which the external environmental cues, together with the complex genetic actions, propagate the inflammatory process that characterize asthma are beginning to be understood. There is also an evolving awareness of the active participation of structural elements, such as the airway epithelium, airway smooth muscle, and endothelium, in this process. In tandem with this has come the realization that inflammatory cells respond in a coordinated, albeit dysfunctional manner, via an array of complex signaling pathways that facilitate communication between these cells; these structural elements within the lung and the bone marrow serve as reservoirs for and the source of inflammatory cells and their precursors. Although often viewed as separate mechanistic entities, so-called innate and acquired immunity often overlap in the propagation of the asthmatic response. This review examines the newer information on the pathophysiologic characteristics of asthma and focuses on papers published over the past 3 years that have helped to improve current levels of understanding.

Citing Articles

Nobiletin, as a Novel PDE4B Inhibitor, Alleviates Asthma Symptoms by Activating the cAMP-PKA-CREB Signaling Pathway.

Zhang Y, Yang Y, Liang H, Liang Y, Xiong G, Lu F Int J Mol Sci. 2024; 25(19).

PMID: 39408735 PMC: 11477036. DOI: 10.3390/ijms251910406.


Application of nano- and micro-particle-based approaches for selected bronchodilators in management of asthma.

Singh S, Aparna , Sharma N, Gupta J, Kyada A, Nathiya D 3 Biotech. 2024; 14(9):208.

PMID: 39184911 PMC: 11343956. DOI: 10.1007/s13205-024-04051-1.


The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.

Gupta J Curr Pharm Biotechnol. 2023; 25(9):1073-1081.

PMID: 37649296 DOI: 10.2174/1389201025666230830125147.


Synthesis and spectroscopic study of novel mixed ligand formula "Artemisinin/Zn" and assessment of its inhibitory effect against "SARS-CoV-2″.

Al-Salmi F, El-Megharbel S, Hamza R Heliyon. 2023; 9(6):e17177.

PMID: 37366527 PMC: 10277259. DOI: 10.1016/j.heliyon.2023.e17177.


Correlation between parents and child's version of the child health survey for asthma questionnaire.

Zhjeqi V, Kundi M, Shahini M, Ahmetaj H, Ahmetaj L, Krasniqi S Eur Clin Respir J. 2023; 10(1):2194165.

PMID: 37006411 PMC: 10054174. DOI: 10.1080/20018525.2023.2194165.